Richard G. Moore

Official portrait, 2024 Richard Garner Moore Jr. is a retired United States Air Force lieutenant general who last served as the deputy chief of staff for plans and programs of the U.S. Air Force from 2022 to 2024. He previously served as director of programs of the U.S. Air Force.

In May 2022, Moore was nominated for promotion to lieutenant general and appointment as deputy chief of staff for plans and programs of the United States Air Force. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Richard G. Moore', query time: 0.02s Refine Results
  1. 1
    Stacking Machine Learning Algorithms for Biomarker-Based Preoperative Diagnosis of a Pelvic Mass

    Stacking Machine Learning Algorithms for Biomarker-Based Preoperative Diagnosis of a Pelvic Mass by Reid Shaw, Anna E. Lokshin, Michael C. Miller, Geralyn Messerlian-Lambert, Richard G. Moore

    Published 2022-03-01
    Get full text
    Article
  2. 2
    Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer

    Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer by Rachael B. Rowswell-Turner, Jennifer A. Rutishauser, Kyu Kwang Kim, Negar Khazan, Umayal Sivagnanalingam, Aaron M. Jones, Rakesh K. Singh, Richard G. Moore

    Published 2019-07-01
    Get full text
    Article
  3. 3
    Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer

    Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer by Kyukwang Kim, Negar Khazan, Rachael B. Rowswell-Turner, Rakesh K. Singh, Taylor Moore, Myla S. Strawderman, John P. Miller, Cameron W. A. Snyder, Ahmad Awada, Richard G. Moore

    Published 2024-02-01
    Get full text
    Article
  4. 4
    Where Are We Now? Systematic Review of Surgical Techniques and Outcomes of Uterine Transplantation

    Where Are We Now? Systematic Review of Surgical Techniques and Outcomes of Uterine Transplantation by Joseph M. Escandón, MD, Valeria P. Bustos, MD, Eric A. Santamaria Linares, MD, Howard N. Langstein, MD, Pedro Ciudad, MD, Roberto Hernandez-Alejandro, MD, Richard G. Moore, MD, Jonathan I. Leckenby, MBBS, PhD, Oscar J. Manrique, MD

    Published 2021-10-01
    Get full text
    Article
  5. 5
    A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System

    A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System by Evan N. Cohen, Gitanjali Jayachandran, Richard G. Moore, Massimo Cristofanilli, Julie E. Lang, Joseph D. Khoury, Michael F. Press, Kyu Kwang Kim, Negar Khazan, Qiang Zhang, Youbin Zhang, Pushpinder Kaur, Roberta Guzman, Michael C. Miller, James M. Reuben, Naoto T. Ueno

    Published 2022-10-01
    Get full text
    Article
  6. 6
    Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1

    Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1 by Negar Khazan, Emily R. Quarato, Niloy A. Singh, Cameron W. A. Snyder, Taylor Moore, John P. Miller, Masato Yasui, Yuki Teramoto, Takuro Goto, Sabeeha Reshi, Jennifer Hong, Naixin Zhang, Diya Pandey, Priyanka Srivastava, Alexandra Morell, Hiroki Kawano, Yuko Kawano, Thomas Conley, Deepak M. Sahasrabudhe, Naohiro Yano, Hiroshi Miyamoto, Omar Aljitawi, Jane Liesveld, Michael W. Becker, Laura M. Calvi, Alexander S. Zhovmer, Erdem D. Tabdanov, Nikolay V. Dokholyan, David C. Linehan, Jeanne N. Hansen, Scott A. Gerber, Ashoke Sharon, Manoj K. Khera, Peter W. Jurutka, Natacha Rochel, Kyu Kwang Kim, Rachael B. Rowswell-Turner, Rakesh K. Singh, Richard G. Moore

    Published 2023-06-01
    Get full text
    Article

Search Tools: